SMTL ID : 8w0i.1

Cryo-EM structure of the human MCM2-7 heterohexamer

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-1-1-1-mer

Ligands

5 x ZN: ZINC ION

ZN.1: 6 residues within 4Å: Chain A: C.329, C.332, F.334, C.352, C.355, S.357 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.329, A:C.332, A:C.352, A:C.355 ZN.6: 7 residues within 4Å: Chain C: C.309, V.311, C.312, H.314, C.331, C.334, T.336 4 PLIP interactions: 4 interactions with chain C Metal complexes: C:C.309, C:C.312, C:C.331, C:C.334 ZN.9: 6 residues within 4Å: Chain D: C.172, C.175, N.177, C.197, P.208, Y.212 3 PLIP interactions: 3 interactions with chain D Metal complexes: D:C.172, D:C.175, D:C.197 ZN.10: 6 residues within 4Å: Chain E: C.158, D.160, C.161, C.180, C.185, N.187 4 PLIP interactions: 4 interactions with chain E Metal complexes: E:C.158, E:C.161, E:C.180, E:C.185 ZN.13: 7 residues within 4Å: Chain F: C.184, Q.186, C.187, C.206, S.208, C.211, G.218 4 PLIP interactions: 4 interactions with chain F Metal complexes: F:C.184, F:C.187, F:C.206, F:C.211

5 x MG: MAGNESIUM ION

MG.2: 4 residues within 4Å: Chain A: S.530, D.587 Chain E: R.529 Ligands: ATP.3 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:S.530 MG.4: 2 residues within 4Å: Chain B: S.354 Ligands: ADP.5 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:S.354 MG.7: 3 residues within 4Å: Chain C: K.519, S.520 Ligands: ATP.8 1 PLIP interactions: 1 interactions with chain C Metal complexes: C:S.520 MG.11: 6 residues within 4Å: Chain C: E.595, R.646, R.735 Chain E: S.403, D.460 Ligands: ATP.12 1 PLIP interactions: 1 interactions with chain E Metal complexes: E:S.403 MG.14: 4 residues within 4Å: Chain B: R.618 Chain F: S.388, D.445 Ligands: ATP.15 1 PLIP interactions: 1 interactions with chain F Metal complexes: F:S.388

4 x ATP: ADENOSINE-5'-TRIPHOSPHATE

ATP.3: 23 residues within 4Å: Chain A: S.484, I.485, Y.486, H.488, P.525, G.526, T.527, A.528, K.529, S.530, Q.531, E.588, N.631, Q.671, L.675, F.678, V.679 Chain E: S.528, R.529, V.618, R.619, E.622 Ligands: MG.2 19 PLIP interactions: 14 interactions with chain A, 5 interactions with chain E Hydrogen bonds: A:Y.486, A:Y.486, A:H.488, A:G.526, A:A.528, A:K.529, A:S.530, A:S.530, A:S.530, A:Q.531, A:E.588, A:N.631, E:E.622 Salt bridges: A:K.529, A:K.529, E:R.529, E:R.619, E:R.619, E:R.619 ATP.8: 25 residues within 4Å: Chain C: S.472, I.473, Y.474, E.475, H.476, D.514, P.515, G.516, T.517, S.518, K.519, S.520, Q.521, E.578, N.621, Y.661, L.665, H.668, L.669 Chain F: R.514, S.602, A.603, R.604, L.607 Ligands: MG.7 19 PLIP interactions: 15 interactions with chain C, 4 interactions with chain F Hydrogen bonds: C:Y.474, C:Y.474, C:H.476, C:D.514, C:G.516, C:T.517, C:T.517, C:S.518, C:S.518, C:S.518, C:K.519, C:S.520, C:Q.521 Salt bridges: C:K.519, C:K.519, F:R.514, F:R.604, F:R.604, F:R.604 ATP.12: 21 residues within 4Å: Chain C: R.500, R.646, P.734, R.735, E.738 Chain E: I.358, H.359, N.361, D.397, P.398, S.399, T.400, A.401, K.402, S.403, Q.404, N.504, I.548, R.551, I.552 Ligands: MG.11 19 PLIP interactions: 6 interactions with chain C, 13 interactions with chain E Hydrogen bonds: C:R.500, C:E.738, E:H.359, E:H.359, E:N.361, E:S.399, E:T.400, E:A.401, E:K.402, E:S.403, E:S.403, E:Q.404, E:N.504 Salt bridges: C:R.646, C:R.735, C:R.735, C:R.735, E:K.402, E:K.402 ATP.15: 22 residues within 4Å: Chain B: I.337, E.429, R.480, A.617, R.618, E.621 Chain F: E.343, I.344, Y.345, H.347, P.383, G.384, V.385, A.386, K.387, S.388, Q.389, N.489, L.533, H.536, I.537 Ligands: MG.14 14 PLIP interactions: 10 interactions with chain F, 4 interactions with chain B Hydrogen bonds: F:Y.345, F:Y.345, F:G.384, F:V.385, F:A.386, F:K.387, F:S.388, F:Q.389, F:N.489, B:E.621 Salt bridges: F:K.387, B:R.618, B:R.618, B:R.618

1 x ADP: ADENOSINE-5'-DIPHOSPHATE

ADP.5: 20 residues within 4Å: Chain B: S.308, I.309, H.310, H.312, P.349, S.350, V.351, A.352, K.353, S.354, Q.355, I.499, H.502, V.503 Chain D: R.371, E.463, V.610, R.611, E.614 Ligands: MG.4 15 PLIP interactions: 11 interactions with chain B, 4 interactions with chain D Hydrogen bonds: B:H.310, B:H.310, B:H.312, B:S.350, B:V.351, B:A.352, B:S.354, B:S.354, B:Q.355, D:R.371, D:E.614 Salt bridges: B:K.353, B:K.353, D:R.611, D:R.611

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yang, R. et al., Multiple pathways for licensing human replication origins. To Be Published

Release Date

2024-10-02

Peptides

DNA replication licensing factor MCM2: A
DNA replication licensing factor MCM3: B
DNA replication licensing factor MCM4: C
DNA replication licensing factor MCM5: D
DNA replication licensing factor MCM6: E
DNA replication licensing factor MCM7: F

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
2

B
3

C
4

D
5

E
6

F
7

DNA replication licensing factor MCM2

DNA replication licensing factor MCM3

DNA replication licensing factor MCM4

DNA replication licensing factor MCM5

DNA replication licensing factor MCM6

DNA replication licensing factor MCM7

Related Entries With Identical Sequence